Table 2.
Potency of HA antigens in NE-adjuvanted vaccines by SRID assay after storage for 48 h at 4°C
| Vaccine and adjuvant | HA potency (μg/ml) of vaccine |
|||||
|---|---|---|---|---|---|---|
| A/Brisbane/59/2007 (H1N1) |
A/Brisbane/10/2007 (H3N2) |
B/Florida/4/2006 |
||||
| 0 h | 48 h | 0 h | 48 h | 0 h | 48 h | |
| Fluzone | 20 ± 1.7 | 22 ± 3.1 | 24 ± 1.5 | 24 ± 2.0 | 18 ± 2.0 | 19 ± 1.7 |
| Fluzone + 5% W805EC | 19 ± 1.7 | 18 ± 1.7 | 20 ± 3.5 | 21 ± 1.5 | 17 ± 2.0 | 17 ± 2.5 |
| Fluzone + 20% W805EC | 17 ± 1.2 | 16 ± 0.6 | 18 ± 0.6 | 16 ± 3.6 | 13 ± 2.6 | 18 ± 2.3 |